Browsing Category
Top Industry News
7072 posts
Gilead Completes $4.3-Bn Acquisition of CymaBay Therapeutics
By
Gilead has completed its $4.3-billion acquisition of CymaBay Therapeutics, a Newark, California-based clinical-stage bio/pharmaceutical company. The deal was announced in February 2024. CymaBay’s lead candidate is seladelpar, an oral drug…
AstraZeneca To Acquire Fusion Pharmaceuticals & Amolyt Pharma in Combined $3.4-Bn Deals
By
AstraZeneca has agreed to acquire two companies in two separate deals: Fusion Pharmaceuticals, a Hamilton, Ontario, Canada-based clinical-stage bio/pharmaceutical company, in a $2.4-deal billion (includes $2 billion upfront), and Amolyt…
BMS Completes $4.1-Bn Acquisition of Radiopharmaceutical Company RayzeBio
By
Bristol Myers Squibb (BMS) has completed its $4,1-billion acquisition of RayzeBio, a San Diego, California-based clinical-stage radiopharmaceutical company, The acquisition was announced in January 2024. RayzeBio has a position in…